| Drug Name |
Bedaquiline fumarate |
| Drug ID |
BADD_D00222 |
| Description |
Bedaquiline is a bactericidal antimycobacterial drug. Chemically it is a diarylquinoline. FDA approved on December 28, 2012. |
| Indications and Usage |
Bedaquiline is indicated as part of combination therapy in adults (≥ 18 years) with pulmonary multi-drug resistant tuberculosis (MDR-TB). |
| Marketing Status |
Prescription |
| ATC Code |
J04AK05 |
| DrugBank ID |
DB08903
|
| KEGG ID |
D09873
|
| MeSH ID |
C493870
|
| PubChem ID |
24812732
|
| TTD Drug ID |
D0Y4QG
|
| NDC Product Code |
59676-702; 59676-701; 69766-058 |
| Synonyms |
bedaquiline | (1R,2S)-1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-(3-fluorophenyl)-1-phenyl-butan-2-ol | R207910 | TMC207 | AIDS222088 | AIDS-222089 | bedaquiline fumarate |
